| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.13 | 0.4 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |